Related Experiment Video
Updated: Sep 5, 2026

Database-guided Flow-cytometry for Evaluation of Bone Marrow Myeloid Cell Maturation
Published on: November 3, 2018
Glomerular involvement in myelodysplastic syndromes
R Bogdanović1, M Kuzmanović, J Marković-Lipkovski
1Institute of Mother and Child Health of Serbia, 8 R. Dakica St., 11070 Belgrade, Yugoslavia. Maloun@eunet.yu
Abstract:
Several reports have documented various forms of glomerular diseases in adults with myelodysplastic syndromes (MDS), but similar reports in children are lacking. We describe two children with MDS-associated steroid-responsive nephrotic syndrome (NS). Patient 1, who had MDS with myelofibrosis, presented with hepatosplenomegaly, pancytopenia, chronic hepatitis, moderate proteinuria, hypocomplementemia and elevated ANA titer. During initial prednisone treatment proteinuria markedly diminished and partial but transient hematological improvement occurred. Relapse subsequently occurred that manifested by overt NS and pancytopenia. High doses of prednisolone led to remission of the renal disease, but hematological remission did not occur. Persisting pancytopenia and repeated infections terminated in sepsis, 2 years after the onset of the MDS. Patient 2, who had refractory anemia with clonal monosomy 19, presented with bowel disease, hepatosplenomegaly, anemia and non-organ-specific autoantibodies. Prednisone led to both clinical and hematological remission. The hematologic disease relapsed 12 months later, when nephrotic-range proteinuria, hematuria and mild azotemia were also found. Corticosteroid treatment led to long-lasting renal and hematologic remission, maintained by a small dosage of prednisone. In both patients, renal biopsy findings were consistent with those seen in idiopathic NS. A Medline search disclosed 16 cases of glomerulopathy in the course of MDS in adult patients. Clinical features included NS, usually accompanied by renal insufficiency with acute, chronic, or rapidly progressive glomerulonephritis. On biopsy, membranous nephropathy, crescentic or mesangial proliferative glomerulonephritis, and AL amyloidosis were found. We conclude: (1) that glomerular disease may be present and should be searched for in patients with MDS and (2) that MDS can be added to the list of rare conditions associated with corticosteroid-responsive NS in children.
Insights
This study highlights myelodysplastic syndromes (MDS) as a cause of steroid-responsive nephrotic syndrome (NS) in children, a rare but important association. Early detection and treatment are crucial for managing these pediatric kidney and blood disorders.
Area of Science:
- Pediatric Nephrology
- Hematology
- Oncology
Background:
- Glomerular diseases are documented in adults with myelodysplastic syndromes (MDS).
- Similar reports in pediatric patients are scarce, necessitating further investigation into this association.
- Myelodysplastic syndromes represent a group of clonal hematopoietic stem cell disorders characterized by ineffective hematopoiesis and a high risk of transformation to acute myeloid leukemia.
Observation:
- Two pediatric cases of myelodysplastic syndromes-associated steroid-responsive nephrotic syndrome (NS) are presented.
- Patient 1 exhibited MDS with myelofibrosis, presenting with pancytopenia and nephrotic syndrome, responsive to high-dose steroids but with persistent hematologic issues.
- Patient 2 had refractory anemia with monosomy 19, experiencing nephrotic syndrome and hematologic relapse responsive to corticosteroids, indicating a potential link between MDS and NS.
Findings:
- Renal biopsy findings in both pediatric patients were consistent with idiopathic nephrotic syndrome.
- A literature review identified 16 adult cases of glomerulopathy associated with MDS, manifesting as NS, renal insufficiency, and various glomerulonephritis types.
- The study suggests that myelodysplastic syndromes can be associated with corticosteroid-responsive nephrotic syndrome in children, expanding the known spectrum of MDS complications.
Implications:
- Pediatricians and hematologists should consider searching for glomerular disease in children diagnosed with myelodysplastic syndromes.
- MDS should be recognized as a potential underlying cause of nephrotic syndrome in pediatric patients, particularly those with steroid-responsive disease.
- This finding contributes to understanding the extraskeletal manifestations of myelodysplastic syndromes and informs diagnostic and therapeutic strategies in affected children.

